Research Article

Related GMR Articles

09/13/2012
Dithranol; Gene expression; HaCaT; Id1; Psoriasis

The precise causes of psoriasis, a chronic skin disorder characterized by hyperproliferation of keratinocytes and incomplete keratinization, are unclear. It is known that expression of helix-loop-helix transcription factor Id1, which functions as an inhibitor of differentiation, is upregulated in psoriatic skin. We investigated the effect of the antipsoriatic drug dithranol on mRNA and ... more

C. Ronpirin; T. Tencomnao
09/30/2005
Bioinformatics; Gene expression analysis; Machine learning; Novelty detection; Support vector machines

Novelty detection techniques might be a promising way of dealing with high-dimensional classification problems in Bioinformatics. We present preliminary results of the use of a one-class support vector machine approach to detect novel classes in two Bioinformatics databases. The results are compatible with theory and inspire further investigation.

E.J. Spinosa; A.C.P.L.F. de Carvalho
06/29/2012
Gene expression analysis; HepG2; NF-kB; RAGEv1; TNF-α

Binding of specific ligands to the receptor for advanced glycation end-products (RAGE) can trigger a series of signal transductions, which leads to pathogenesis in many chronic degenerative diseases, including cancer. Alternative splicing of RAGE mRNA has resulted in many variants, including RAGE variant 1 (RAGEv1). This particular splice variant of RAGE can provide a major soluble form ... more

T. Lertwittayapon; T. Tencomnao; R. Santiyanont
04/02/2013
Apoptosis; Invasion; miR-181b; PC-3; Proliferation; Prostate cancer

We examined microRNA-181b (miRNA) expression in prostate cancer tissues and its effect on the prostate cancer cell line PC-3. Tissues from 27 cases of prostate cancer and 30 samples of normal human prostate were collected by surgical removal. Total miRNA was extracted, and the relative expression of miR-181b was quantified using RT-PCR. miR-181b ASO was transfected into prostate cancer PC ... more

L. He; H. Yao; L.H. Fan; L. Liu; S. Qiu; X. Li; J.P. Gao; C.Q. Hao
08/25/2014
Mesenchymal stem cell; Osteoblast differentiation; Proliferation; Rifampicin

This study was designed to investigate the effect of different concentrations of rifampicin on osteogenic differentiation and proliferation of mesenchymal stem cells (MSCs) in human bone marrow. Rifampicin treatment at 0, 4, 8, 16, 32, 64, and 128 mg/mL was applied throughout the whole process, from stromal cells purified from human bone marrow to differentiated bone cells. The effect of ... more

Z. Zhang; X. Wang; F. Luo; H. Yang; T. Hou; Q. Zhou; F. Dai; Q. He; J. Xu
10/24/2013
Functional similarity; Gene set; miRNA; mRNA; Prostate cancer; Target gene

Annotation of prostate cancer (PC) genomes provides a foundation for discoveries that can improve the understanding and treatment of the disease. Therefore, in the present study, we used the Student t-test to identify differentially expressed PC-related mRNAs and microRNAs (miRNAs). Then, we performed interrelated mapping of miRNA target genes between abnormally expressed mRNAs ... more

H. Song; Y. Liu; J. Pan; S.T. Zhao
05/09/2012
Adipose; MDH1; MDH2; ME1; mRNA; Pig; qRT-PCR

Malate dehydrogenases 1 and 2 (MDH1 and MDH2), and malic enzyme 1 (ME1) play important roles in the Krebs cycle for energy metabolism. The mRNA abundance changes of MDH1, MDH2 and ME1 genes were measured across six different adipose tissues from the leaner Landrace and fatty Rongchang pig breeds using quantitative real-time PCR. The ... more

S.L. Zhou; M.Z. Li; Q.H. Li; J.Q. Guan; X.W. Li
12/04/2014
Excision repair cross-complementing group 1; mRNA; Non-small cell lung cancer; Response to chemotherapy; Ribonucleotide reductase subunit M1; Survival

We conducted a prospective study to analyze the expression of the excision repair cross-complementing group 1 (ERCC1) and ribonucleotide reductase subunit M1 (RRM1) genes in 297 Chinese patients with advanced non-small cell lung cancer (NSCLC). The goal of this study was to evaluate these genes as potential biomarkers for prediction of tumor response and clinical outcome ... more

H. Zhang; J. Li; Y. Zhang; M. Sun; P. Zhao; G. Zhang; C. Jin; L. Sun; M. He; B. Wang; X. Zhang
12/08/2011
Corneodesmosin; Gene polymorphism; Meta-analysis; Psoriasis; Risk

Previous studies investigating the association between corneodesmosin (CDSN) polymorphisms and psoriasis risk have provided inconsistent results. The aim of our study was to clarify the effects of CDSN -619C/T polymorphism on psoriasis risk by conducting a meta-analysis. We conducted searches of the published literature in Pubmed and Embase databases up to October 2010. Six studies with a ... more

Y. Wu; B. Wang; J.L. Liu; X.H. Gao; H.D. Chen; Y.H. Li
12/15/2011
Human leukocyte antigen; Meta-analysis; Polymorphism; Psoriasis; Risk

Numerous studies have evaluated the association between human leukocyte antigen (HLA) Cw*0602 polymorphism and psoriasis risk. However, the results have been inconsistent. We made a meta-analysis of the association between HLA-Cw*0602 polymorphism and psoriasis risk. Eighteen studies were retrieved, reporting a total of 3419 psoriasis patients and 3297 healthy controls. The associations ... more

D. Wu; Y. Wu; J.L. Liu; B. Wang; X.D. Zhang

Pages